Liver Disease in Cystic FibrosisLeeuwen, L., Fitzgerald, D. A. & Gaskin, K. J., Mar-2014, In : Paediatric respiratory reviews. 15, 1, p. 69-74 6 p.
Research output: Contribution to journal › Review article › Academic › peer-review
The survival of patients with cystic fibrosis (CF) has progressively increased over recent decades, largely attributable to early diagnosis through newborn screening and advances in nutritional and respiratory care. As the life expectancy of patients with CF has improved, non-respiratory complications such as liver disease have become increasingly recognized.
Biochemical derangements of liver enzymes in CF are common and may be attributed to a number of specific hepatobiliary abnormalities. Among them, Cystic Fibrosis-associated Liver Disease (CFLD) is clinically the most significant hepatic complication and is believed to have a significant impact on morbidity and mortality. However, there remains much conjecture about the extent of the adverse prognostic implications that a diagnosis of CFLD has on clinical outcomes. The purpose of this review is to give an overview of the current knowledge regarding liver disease in children with CF. Crown Copyright (c) 2013 Published by Elsevier Ltd. All rights reserved.
|Number of pages||6|
|Journal||Paediatric respiratory reviews|
|Publication status||Published - Mar-2014|
- Cystic Fibrosis, Cystic Fibrosis-associated Liver Disease, Cholestasis, Morbidity, Mortality, Liver transplantation, URSODEOXYCHOLIC ACID, RISK-FACTORS, PORTAL-HYPERTENSION, HEPATOBILIARY DISEASE, NUTRITIONAL-STATUS, BILIARY-CIRRHOSIS, EPITHELIAL-CELLS, BILE-ACIDS, TRANSPLANTATION, CHOLESTASIS